York Gwill
SEC insider (Form 3/4/5 filer). CIK 0002008499. Director at Alto Neuroscience, Inc. (ANRO). 4 reported Form 4/5 transactions since Sep 2024; latest on May 12, 2026. Located in MOUNTAIN VIEW, CA.
Companies York Gwill has filed insider reports for
- Alto Neuroscience, Inc. (ANRO): Director
York Gwill
CIK: 0002008499
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Alto Neuroscience, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 12, 2026ANRO
Alto Neuroscience, Inc.
AwardDirectStock Option (right to buy)
11K shares- - Jan 2, 2026ANRO
Alto Neuroscience, Inc.
AwardDirectStock Option (right to buy)
5.2K shares at avg. $11.82- - May 13, 2025ANRO
Alto Neuroscience, Inc.
AwardDirectStock Option (right to buy)
15.3K shares- - Jan 2, 2025ANRO
Alto Neuroscience, Inc.
AwardDirectStock Option (right to buy)
19.6K shares at avg. $3.17-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 12, 2026 | ANRO Alto Neuroscience, Inc. | Award Stock Option (right to buy) | 10,958 | - | - | Direct |
| Jan 2, 2026 | ANRO Alto Neuroscience, Inc. | Award Stock Option (right to buy) | 5,243 | $11.82 | - | Direct |
| May 13, 2025 | ANRO Alto Neuroscience, Inc. | Award Stock Option (right to buy) | 15,287 | - | - | Direct |
| Jan 2, 2025 | ANRO Alto Neuroscience, Inc. | Award Stock Option (right to buy) | 19,558 | $3.17 | - | Direct |
1-4 of 4 transactions